Bathi operasional sadurunge amortisasi: Check-Cap Ltd. (CHEK)

Logo perusahaan publik Check-Cap (CHEK)

The high market potential for non-invasive colorectal cancer screening contrasts with the volatility captured by the GURU.Markets portal in the absolute EBITDA trend, where the metric level stands at 0.00. This price action is driven by a deep business restructuring and a strategic bet on C-Scan patents. Growth is expected following FDA approval and the launch of capsule diagnostics in the US, which will ensure a steady cash flow for Check-Cap Ltd. (CHEK).

CHEK Check-Cap Medical: Bathi sadurunge mbayar bunga, pajak, lan amortisasi ing interval 23.11.2025 - 28.11.2025

Ringkesan rincian data analitis Check-Cap (CHEK)

- rega pasar lan target rega analis:
Rega saham Check-Cap Ltd|CHEK - Bagan rega target
- indikator kapitalisasi bursa perusahaan:
Kapitalisasi pasar Check-Cap|CHEK - Nilai Perusahaan
- indikator nilai aset resik miturut neraca:
Nilai Buku saben Saham Check-Cap|CHEK - Nilai Buku Perusahaan|Rasio Nilai Pasar marang Nilai Buku check-cap.com|CHEK - Gunggung Aset Perusahaan
- rincian struktur utang lan likuiditas bisnis:
Utang marang Modal Check-Cap Ltd.|CHEK - Utang jangka dawa marang ekuitas|Koefisien utang jangka cendhak marang modal Check-Cap Ltd|CHEK - Gunggung utang perusahaan|Utang-utang marang aset resik Check-Cap|CHEK - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Check-Cap|Indikator likuiditas cepet check-cap.com
- data bathi bisnis lan rasio investasi:
CHEK - Bathi resik|Penghasilan resik sing dikarepake Check-Cap Ltd.|CHEK - Pangali P/E|Rasio prakiraan rega marang bathi Check-Cap Ltd|CHEK - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Check-Cap|CHEK - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Check-Cap|CHEK - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi resik saben saham sajroning taun lumaku check-cap.com|CHEK - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Check-Cap Ltd.
Ringkesan analitik perusahaan:CHEK Check-Cap Ltd.
Produk asil prodhuksi Check-Cap Ltd.

Check-Cap Ltd. (CHEK) aggregated EBITDA reflects the actual cash flow from the commercialization of the C-Scan system, excluding non-cash expenses and the impact of capital structure. This metric captures the operational maturity of the business: a stable trend indicates the systemic implementation of non-contact diagnostics, while sharp fluctuations signal a stage of active scaling for the innovative product within the medical screening market.

Pesaing Check-Cap Ltd. (CHEK)

Bathi operasional EBITDA Caris Corp CAI|GH - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|VCYT (veracyte.com) - Bathi operasional sadurunge amortisasi|CELC: Bathi operasional EBITDA|GRAIL Inc (GRAL) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Myriad Genetics Corp|Bathi sadurunge mbayar bunga, pajak, lan amortisasi CSTL|Bathi operasional sadurunge ngurangi amortisasi BNR (Burning Rock Biotech)|VNRX - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Biodesix BDSX|Pendapatan operasional sadurunge ngurangi amortisasi Precipio Inc. (PRPO)|Mainz Biomed - Bathi operasional EBITDA|Pendapatan operasional sadurunge ngurangi amortisasi OncoCyte Inc OCX